Miram
Analyst
JPMorgan
Equibles does not estimate personal net worth.
About Miram
Miram is recorded as Analyst at JPMorgan. Miram has spoken on 1 investor event across 1 company, most recently for Rocket Pharmaceuticals, Inc. on March 27, 2026. The companies whose calls Miram spoke on are classified in the Healthcare sector.
Miram on recent calls
“What is the right way to think about the amount of data the FDA would want to see from treated patients in the ongoing clinical study and post-marketing registry to adjust accelerated approval to a traditional approval?”
Affiliation history
-
JPMorgan
Analyst
Transcript header (unverified)
Current